ANAVEX ANAVEX2-73-AD-004
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer’s Disease (AD).
